Why @adamfeuerstein believes Novartis is going to walk away from its acquisition...
Vertex’s once-daily cystic fibrosis therapy succeeded in a pair of Phase 3 studi...
Johnson & Johnson faces a consequential new class action lawsuit for allegedly o...
Fatigue is common among long Covid patients, which means that recommendations to...
The case study, about how Krystal Biotech's gene therapy for a rare genetic cond...
The government boiled down its rules about Medicare Advantage plans using AI to ...
Working with the cells of people with peanut allergies, researchers identify a "...
Health Canada has approved Chiesi Global Rare Diseases’ MYALEPTA as a treatment ...
Silence Therapeutics has announced a private placement of its 5,714,286 American...
Incyte has acquired sole worldwide rights to tafasitamab immunotherapy through a...
CB-012 is a gene-modified cell therapy commercialized by Caribou Biosciences, wi...
RT-111 could offer an alternative dosing regimen for patients with psoriasis and...
Pending a successful acquisition, Novartis will obtain pelabresib for myelofibro...
The potentially disastrous consequences of antimicrobial resistance (AMR) were h...
The Belgian women’s health company is exploring multiple asset and licensing sel...
The China NMPA has granted clearance for the investigational new drug (IND) appl...
